These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 17933490

  • 1. Gene expression profiling in livers of mice after acute inhibition of beta-oxidation.
    van der Leij FR, Bloks VW, Grefhorst A, Hoekstra J, Gerding A, Kooi K, Gerbens F, te Meerman G, Kuipers F.
    Genomics; 2007 Dec; 90(6):680-9. PubMed ID: 17933490
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Nakamuta M, Kohjima M, Morizono S, Kotoh K, Yoshimoto T, Miyagi I, Enjoji M.
    Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
    [Abstract] [Full Text] [Related]

  • 3. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES, Tian L, Wood PA.
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [Abstract] [Full Text] [Related]

  • 4. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS, Kim JH, Jo NY, Choi KM, Baik SH, Park JJ, Kim JS, Byun KS, Bak YT, Lee CH, Kim A, Yeon JE.
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [Abstract] [Full Text] [Related]

  • 5. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
    Vickers AE, Bentley P, Fisher RL.
    Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
    [Abstract] [Full Text] [Related]

  • 6. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS, Cooney GJ.
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [Abstract] [Full Text] [Related]

  • 7. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production.
    Grefhorst A, Hoekstra J, Derks TG, Ouwens DM, Baller JF, Havinga R, Havekes LM, Romijn JA, Kuipers F.
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G592-8. PubMed ID: 15817811
    [Abstract] [Full Text] [Related]

  • 8. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
    Yeon JE, Choi KM, Baik SH, Kim KO, Lim HJ, Park KH, Kim JY, Park JJ, Kim JS, Bak YT, Byun KS, Lee CH.
    J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
    Yu HY, Wang BL, Zhao J, Yao XM, Gu Y, Li Y.
    Toxicology; 2009 Jul 10; 261(3):112-8. PubMed ID: 19427351
    [Abstract] [Full Text] [Related]

  • 10. Dietary trans 10, cis 12-conjugated linoleic acid reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver.
    Rasooly R, Kelley DS, Greg J, Mackey BE.
    Br J Nutr; 2007 Jan 10; 97(1):58-66. PubMed ID: 17217560
    [Abstract] [Full Text] [Related]

  • 11. Identification of promethin and PGLP as two novel up-regulated genes in PPARgamma1-induced adipogenic mouse liver.
    Yu S, Viswakarma N, Batra SK, Sambasiva Rao M, Reddy JK.
    Biochimie; 2004 Nov 10; 86(11):743-61. PubMed ID: 15589683
    [Abstract] [Full Text] [Related]

  • 12. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.
    Eur J Gastroenterol Hepatol; 2008 Sep 10; 20(9):843-54. PubMed ID: 18794597
    [Abstract] [Full Text] [Related]

  • 13. Elevated hepatocyte levels of the Forkhead box A2 (HNF-3beta) transcription factor cause postnatal steatosis and mitochondrial damage.
    Hughes DE, Stolz DB, Yu S, Tan Y, Reddy JK, Watkins SC, Diehl AM, Costa RH.
    Hepatology; 2003 Jun 10; 37(6):1414-24. PubMed ID: 12774021
    [Abstract] [Full Text] [Related]

  • 14. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression.
    Sugatani J, Wada T, Osabe M, Yamakawa K, Yoshinari K, Miwa M.
    Drug Metab Dispos; 2006 Oct 10; 34(10):1677-87. PubMed ID: 16815962
    [Abstract] [Full Text] [Related]

  • 15. Altered lipid catabolism in the vitamin A deficient liver.
    Kang HW, Bhimidi GR, Odom DP, Brun PJ, Fernandez ML, McGrane MM.
    Mol Cell Endocrinol; 2007 Jun 15; 271(1-2):18-27. PubMed ID: 17467165
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatic gene expression profiling and lipid homeostasis in mice exposed to steatogenic drug, tetracycline.
    Yin HQ, Kim M, Kim JH, Kong G, Lee MO, Kang KS, Yoon BI, Kim HL, Lee BH.
    Toxicol Sci; 2006 Nov 15; 94(1):206-16. PubMed ID: 16917069
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.